THURSDAY, April 8 (HealthDay News) -- The first generic versions of two drugs to treat high blood pressure, Cozaar (losartan potassium) and Hyzaar (losartan potassium and hydrochlorothiazide), have been approved by the U.S. Food and Drug Administration.
The generic versions will carry the same label warnings that they should not be used by pregnant women during their second or third trimesters, the agency said in a news release.
The brand-name versions of both drugs are manufactured by Merck & Co. Licenses to produce generics of one or both medications were granted to a number of firms, including Teva Pharmaceuticals, Mylan Pharmaceuticals, Roxane Laboratories and Torrent Pharmaceuticals, the FDA said.
More information
The FDA has more about generic drugs.
